Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr₹2,588 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,209 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,209 Cr
Mar2024₹3,743 Cr
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr
Mar2021₹2,588 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,209 Cr
12.45
Mar2024 ₹3,743 Cr
12.02
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr
11.66
Mar2021 ₹2,588 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹36,073.0 Cr 6.9% -3.5% 12.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹99,086.7 Cr 0.8% -9.1% -13.1% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

6.9%

-3.5%

12.6%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses